Fantofarone
Alternative Names: SR 33557Latest Information Update: 06 Nov 2001
At a glance
- Originator Sanofi-Synthelabo
- Class Antiarrhythmics; Antihypertensives; Indolizines; Ischaemic heart disorder therapies; Phenethylamines
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias; Hypertension
Most Recent Events
- 06 Nov 2001 Discontinued - Unspecified phase Arrhythmias in USA (Unknown route)
- 06 Nov 2001 Discontinued - Unspecified phase Hypertension in France (Unknown route)
- 06 Nov 2001 Discontinued - Unspecified phase in Angina pectoris in Belgium (Unknown route)